Australian society scraps PPI guideline after physician outrage — 4 insights

An Australian professional society’s attempt to ban repeat standard-dose proton pump inhibtors prescriptions for gastroesophageal reflux patients was scrapped after several physicians protested, Pharmacy News reports.

Advertisement

Here’s what you should know:

1. PBAC issued the recommendation at a meeting earlier in the year. The society wanted to curb long-term PPI use at anything other than the lowest doses.

2. The group would have continued allowing PPIs to be used if GERD patients had their diagnosis confirmed via endoscopy.

3. Physicians argued the rules were “clinically not necessary and burdensome for patients.”

4. PBAC did, however, propose changing criteria for the PPIs in question to streamlined authority status.

More articles on gastroenterology:
How Carilion Clinic’s Dr. T.K. Miller plans to grow his practice + best advice for new surgeons
Outpatient spine — Key trends and opportunities from Dr. Bobby Bhatti
3 ways patient financing improves patient satisfaction

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.